Is there any progress in routine management of lung cancer patients? A comparative analysis of an institution in 1996 and 2006

Radiology and Oncology

Volumn 43, Issue 1, 2009, Pages 47-53

  Debevec, Lučka ^a   Jerič, Tina ^a   Kovač, Viljem ^b   Bitenc, Marko ^a   Sok, Miha ^c  

^a UNIVERSITY CLINIC OF RESPIRATORY AND ALLERGIC DISEASES   (Slovenia)

^b INSTITUTE OF ONCOLOGY   (Slovenia)

^c UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Diagnostics; Lung cancer; Survival; Therapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; LUNG CANCER; LUNG LOBECTOMY; LUNG RESECTION; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PATIENT ASSESSMENT; PATIENT CARE; RADIOFREQUENCY ABLATION; THORACOTOMY;

EID: 62949138043     PISSN: 13182099     EISSN: 15813207     Source Type: Journal    
DOI: 10.2478/v10019-009-0008-x     Document Type: Article

References (12)

1. Debevec L, Debeljak A, Eržen J, Kovač V, Kern I. Characterization of lung cancer patients, their actual treatment and survival: experience in Slovenia. Radiol Oncol 2005; 39: 115-21.
2. UICC International Union Against Cancer. TNM classification of malignant tumours. Sobin LH, Wittekind CH, editors, Sixth edition. New York: Wiley-Liss; 2002. p. 99-103.
3. Debevec L, Erzen J, Debeljak A, Crnjac A, Kovac V. Exploratory thoracotomy and its influence on the survival of patients with lung cancer. Wien Klin Wochenschr 2006; 118: 479-84.
4. Ilievska Poposka B, Smickova S, Jovanovska Crvenkovska S, Zafirova Ivanovska B, Stefanovski T, Petrusevska G. Prognostic value of immunohistochemical expression of HER-2/neu in patients with lung carcinoma. Radiol Oncol 2008; 42: 151-8.
5. Debevec L, Cesar R, Kern I. Triple synchronous cancers: a medical and ethical problem. Radiol Oncol 2007; 41: 80-5.
6. Free CM, Ellis M, Beggs L, Beggs D, Morgan SA, Baldwin DR. Lung cancer outcomes at a UK cancer unit between 1998-2001. Lung Cancer 2007;57: 222-8.
7. Fernandez V, Alonso JL, Munuera L, Moya JL, Lasa B, Suarez A, et al. Analysis of lung cancer cases diagnosed in an internal medicine department: from January 2001 to September 2006. An Sist Sanit Navar 2007; 30: 353-62.
8. de Cos JS, Miravet L, Abal J, Nunez A, Munoz FJ, Garcia L, et al. Lung cancer survival in Spain and prognostic factors: a prospective, multiregional study. Lung Cancer 2008; 59: 246-54.
9. Erridge SC, Murray B, Price A, Ironside J, Little F, Mackean M, et al. Improved treatment and survival for lung cancer patients in South-East Scotland. J Thorac Oncol 2008; 3: 491-8.
10. Leo F, Venissac N, Poudenx M, OttoJ, Mouroux J, and the Groupe d'Thoracique Azureen (GOThA). Multidisciplinary management of lung cancer: how to test its efficacy? J Thorac Oncol 2007; 2: 69-72.
11. Cancer Registry of Slovenia. Cancer incidence in Slovenia 2004. Report No. 46. Ljubljana: Institute of Oncology Ljubljana; 2007. p. 28-9.
12. Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, et al; EUROCARE-4 Working Group. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 2007; 8: 784-96.